Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 8/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6313162 | 0.78 | ALDH1A1 (0.56) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL5749705 | 0.78 | ALDH1A1 (0.56) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL11626115 | 0.77 | RAB9A (0.61) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL1420797 | 0.76 | ALDH1A1 (1.00) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL1424406 | 0.75 | ALDH1A1 (0.72) | ALDH1A1RAB9ANPC1TP53SMN1; SMN2 | |
| SCHEMBL5107204 | 0.74 | ALDH1A1 (0.52) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL3153578 | 0.74 | ALDH1A1 (0.56) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL19846240 | 0.74 | RAB9A (0.38) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL5565469 | 0.73 | ALDH1A1 (0.51) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL14874962 | 0.72 | MAPT (0.53) | ALDH1A1MAPTRAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | UDC IRELAND LIMITED (IE) | 2023-08-29 | — | — | US | disclosed |
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | UDC IRELAND LIMITED (IE) | 2023-08-29 | — | — | US | disclosed |
| US-20210083200-A1 | Benzimidazo[1,2-a]Benzimidazole Derivatives for Electronic Applications | UDC IRELAND LTD (IE) | 2021-03-18 | — | — | US | disclosed |
| EP-3318566-B1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | UDC IRELAND LTD (IE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3328860-B1 | PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES | UDC IRELAND LTD (IE) | 2020-03-04 | — | — | EP | disclosed |
| US-10570136-B2 | Process for the preparation of benzimidazo[1,2-a] benzimidazoles | UDC IRELAND LIMITED (IE) | 2020-02-25 | — | — | US | disclosed |
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2019-10-01 | — | — | US | disclosed |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | UDC IRELAND LTD (IE) | 2019-09-05 | — | — | US | disclosed |
| US-20190131547-A1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | UDC IRELAND LTD (IE) | 2019-05-02 | — | — | US | disclosed |
| US-10249827-B2 | Azadibenzofurans for electronic applications | UDC IRELAND LIMITED (IE) | 2019-04-02 | — | — | US | disclosed |
| US-20140252280-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-09-11 | — | — | US | disclosed |
| US-20140252280-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-09-11 | — | — | US | disclosed |
| WO-2014044722-A1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-03-27 | — | — | WO | disclosed |
| WO-2013068376-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2013-05-16 | — | — | WO | disclosed |
| WO-2012130709-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-10-04 | — | — | WO | disclosed |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2012-09-27 | — | — | US | disclosed |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2012-09-27 | — | — | US | disclosed |
| EP-0757681-B1 | CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-5834463-A | CONTROLLING FERTILITY, MENSTRUAL CYCLES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-10 | — | — | US | disclosed |
| WO-1995029900-A1 | CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210083200-A1 | Benzimidazo[1,2-a]Benzimidazole Derivatives for Electronic Applications | PAICS, EIF4A1, ECI1 | ALDH1A1 122/4885MAPT 2317/4885RAB9A 1588/4885 |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | EIF4A1, ITPR2, ITPR1 | ALDH1A1 355/4885MAPT 1159/4885RAB9A 764/4885 |
| US-10570136-B2 | Process for the preparation of benzimidazo[1,2-a] benzimidazoles | CYP3A4, CYP2C19, CYP1B1 | ALDH1A1 57/4885MAPT 2400/4885RAB9A 2804/4885 |
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | EIF4A1, ITPR2, ITPR1 | ALDH1A1 355/4885MAPT 1159/4885RAB9A 764/4885 |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | PAH, NISCH, KCNH1 | ALDH1A1 405/4885MAPT 1665/4885RAB9A 447/4885 |
| US-20190131547-A1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | AZI2, BRPF1, CCNB1 | ALDH1A1 547/4885MAPT 4528/4885RAB9A 2061/4885 |
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | PAICS, EIF4A1, ECI1 | ALDH1A1 122/4885MAPT 2317/4885RAB9A 1588/4885 |
| US-10249827-B2 | Azadibenzofurans for electronic applications | AZI2, BRPF1, CCNB1 | ALDH1A1 547/4885MAPT 4528/4885RAB9A 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.